53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
At CHEST 2025, held in Chicago, Illinois, Laurie Slovarp, PhD, CCC-SLP, professor at the University of Montana and certified speech pathologist, presented a poster on the development of a digital therapeutic designed to improve access to behavioral cough suppression therapy for patients with refractory chronic cough.
A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.
This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.
Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.
Abstracts from the 2023 American Cough Conference: ACC2307: Validation of the Hyfe Cough Monitoring System" by Matthew Rudd, Isabel Sanchez-Olivieri, Sarah A R Siegel, and others,.
Authors: Matthew Rudd, Isabel Sa´nchez-Olivieri, Sarah A R Siegel, PeterM Small, Mindaugas Galvosas, Reid Moorsmith, Juan Pablo De Torres, Kevin L Winthrop, Carlos Chaccour
This abstract from the 2023 American Cough Conference: “ACC2307 - Validation of the Hyfe Cough Monitoring System” focuses on assessing the accuracy and reliability of the Hyfe Cough Monitor system. The system utilizes AI-powered capabilities for continuous and non-intrusive monitoring of coughs. The validation study aimed to establish a high correlation in the system's performance for both cough detection and cough duration measurement. This technology is expected to enhance patient care, aid cough research, and support drug development by providing precise and unobtrusive cough monitoring
